David Miller, Author at iPharmg

FDA Grants Priority Review to Insmed’s Brensocatib for...

3 months ago

BRIDGEWATER, N.J., Feb. 6, 2025 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a...

3 months ago

CINCINNATI- February 10, 2025 –LIB Therapeutics Inc. (LIB), a privately-held, late-stage...

3 months ago

TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ:...

3 months ago

NEW HAVEN, Conn., Feb. 11, 2025 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) (Biohaven or the...

3 months ago

DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) — Chimerix (NASDAQ: CMRX), a biopharmaceutical...

3 months ago

WARREN, N.J., Feb. 19, 2025 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced...

3 months ago

With the approval, FDA granted SpringWorks a rare pediatric disease priority review voucher.

3 months ago

This site was previously the beneficiary of a €7.3 million (US$7.6 million) investment, made in...

3 months ago

Obesity is a significant global health challenge that requires lifestyle changes and effective...

3 months ago

In this exclusive Drug Digest video interview Anil Kane from Thermo Fisher Scientific will be...